Arizona Tribune - Boulevard

NYSE - LSE

JRI	-0.4%	12.35	$
CMSD	0%	21.18	$
CMSC	-0.09%	21.29	$
BCE	0.26%	23.46	$
RELX	0.66%	36.54	$
BCC	-0.03%	78.75	$
RBGPF	0.11%	70.77	$
BTI	-0.27%	56.13	$
GSK	1.08%	50.82	$
RYCEF	-1.22%	20.5	$
VOD	1%	16.04	$
RIO	-1.43%	103.3	$
AZN	-1.12%	162.7	$
BP	-0.45%	42.15	$
NGG	-0.1%	79.35	$

Featured

At least 8 die, more missing, as ferry capsizes off Northern Cyprus

A passenger ferry capsized and sank off Northern Cyprus Sunday, killing at least eight people and leaving more than a dozen missing, officials and media reports said, as police took the captain and seven crew members into custody.

British woman dies after stabbing at German station

A 31-year-old British woman died in hospital after being stabbed at Rosenheim railway station in southern Germany.

Last news

Nepra Foods Inc. Issues Clarification on CEO Letter Disclosure

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / September 16, 2025 / Nepra Foods Inc. (CSE:NPRA)(OTCQB:NPRFF) ("Nepra" or the "Company") issues the following clarification at the request of the Canadian Investment Regulatory Organization (CIRO), regarding its press release dated September 11, 2025, titled "Nepra Foods Issues Letter from CEO."

Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025

DENVER, CO / ACCESS Newswire / September 16, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its fiscal 2025 full year and fourth quarter, after the market close on Tuesday, September 23, 2025. The Company has scheduled a conference call and webcast that same day, Tuesday, September 23, 2025, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.

TruMerit Adds Two More Global Credentials for Rehabilitation Care Workers

The Certified Global Health Worker-Rehabilitation (CGHW-R) and the Certified Global Health Worker-Rehabilitation Advanced (CGHW-RA) have been developed specifically for eligible health workers worldwide who wish to have their applied experience and competencies in rehab care recognized and verified by passing a certification examination. These credentials, along with the Certified Global Nurse-Rehabilitation (CGN-R) that TruMerit established last year, are intended to advance and improve services for the more than two billion people worldwide who need this care.

Texas Monthly is Bringing a New Barbecue Event to North Texas

The Texas Monthly BBQ Family Reunion at Grand Prairie's EpicCentral will feature some of the top barbecue legends from across the state.

Climate-Consciousness Week Launches in NYC

Healing Ourselves & Healing Systems - Climate, Consciousness & Mental Health Summit Kicks Off Programming Sept. 17, 5-10pm

Dolphin Subsidiary 42West's Clients Score 5 Primetime Emmy Wins

LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 16, 2025 / The entertainment PR and marketing powerhouse 42West, a subsidiary of Dolphin (NASDAQ:DLPN), congratulates its clients on their wins at the 77th Primetime Emmy Awards, collaborating for a total of five wins.

High BMI FTM Top Surgery Without Limits: Dr. Javad Sajan Offers Inclusive, Life-Saving Gender-Affirming Top Surgery

The Best FTM Top Surgeon in the US is Dr. Javad Sajan at Allure Esthetic

AmICredible Launches, Making Online Credibility Accessible and Measurable

Innovative application offers transparency, restoring trust to internet conversations

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing efficiently, Cohort 4 open for enrollment

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™ pre-workout:50mg caffeine for energy and focus.Boosts performance potential.Stick packs:Convenient, no water needed.Precise caffeine doseGlobal Market Insights: Pre-Workout SupplementsMarket Size in 2024: $19.6 billionProjected Market Size by 2030: $27.9 billionCompound Annual Growth Rate (CAGR): 5.9%

Avel eCare Honors Telehealth Awareness Week with Theme "Powered by People"

SIOUX FALLS SD / ACCESS Newswire / September 16, 2025 / Avel eCare is proud to join healthcare organizations nationwide in celebrating Telehealth Awareness Week, September 14-20, 2025. This year, Avel is honoring the week with a unique theme: Powered by People.

Allied OMS Expands into Greater Austin through Partnership with Heart of Texas Oral Surgery

SOUTHLAKE, TX AND AUSTIN, TX / ACCESS Newswire / September 16, 2025 / Allied OMS, the nation's leading doctor-owned and doctor-led management services organization (MSO) for oral and maxillofacial surgeons, today announced its entry into the Greater Austin market through a partnership with Heart of Texas Oral Surgery.

MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals

MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD

CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025

The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale beverage distribution in sports stadiums nationwide.

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groupsClinical findings reinforce preclinical data supporting recent FDA approval of 2025-2026 formula of Spikevax

White House vows to take on left-wing 'terror' movement after Kirk killing

Senior White House official Stephen Miller vowed Monday that the Trump administration would dismantle an alleged "vast domestic terror movement" that he said led to the killing of right-wing activist Charlie Kirk last week.

Rubio backs Israel in goal to eradicate Hamas

US Secretary of State Marco Rubio on Monday backed Israel's new offensive on Gaza City and the goal of eradicating Hamas, casting doubt on whether diplomacy would work to end nearly two years of war.

UK aristocrat, partner get 14 years for baby daughter's manslaughter

A British woman from an aristocratic family and her partner were Monday jailed for 14 years each for the manslaughter of their newborn daughter, who died while they were living off-grid in freezing temperatures.

Three French women accused of IS links go on trial

Three French women including a niece of notorious jihadist propagandists went on trial in Paris on Monday, accused of travelling to the Middle East to join the Islamic State group and taking their eight children with them.

UK aristocrat, partner face jail over baby daughter's death

A British woman from an aristocratic family and her convicted rapist partner face jail Monday over the manslaughter of their newborn daughter who died while they were living off-grid in freezing temperatures.

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025

DORADO, PUERTO RICO / ACCESS Newswire / September 15, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and nine months ended July 31, 2025 were approximately $2.0 million and $6.9, million, respectively. Revenues for the three and nine months ended July 31, 2024 were approximately $2.4 million and $7.2 million, respectively. Net loss for the three and nine months ended July 31, 2025 was approximately $0.2 million and $0.1 million, respectively, an earnings increase of approximately $0.1 million and $0.7 million when compared to the same periods last year, respectively.

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

This release contains a headline correction from the previous publication.Positive start to FY 2026 with steady revenue, data growth and new leadership

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

Positive start to FY 2026 with steady revenue, data growth and new leadership

New to The Street’s Esteemed Partner/Client - Skip Barber Racing and World Series of Golf(R) Announce Two-Year Luxury Sports Series at Gran Reserva

From elite golf tournaments to supercar driving simulators and a new racetrack debut, this exclusive Mexico-based event redefines luxury sporting experiences.

The Battery Show North America Celebrates 15 Years as EV and Battery Leaders Tackle Production, Supply Chain and Workforce Challenges

The U.S. Department of Energy, LG, General Motors, SK On and Battery Advisor speak on the EV and Battery ecosystems

PAO Group Inc Announces New CEO James Schramm

OMAHA, NE / ACCESS Newswire / September 15, 2025 / PAO Group, Inc. (OTC:PAOG), today announced the appointment of James Schramm as Chief Executive Officer of PAO Group, Inc. In a meeting of the Board of Directors, Mr. Schramm was named CEO and James C DiPrima will step down as CEO and remain Chief Financial Officer. The action was taken in response to the new direction the Company is taking, as the Company will be pursuing a similar path that Mr. Schramm had been successful at with LAW 90.

#paid Releases Updated Creator Insights Report, Giving Brands First-Mover Advantage on Creator Life Moments

The Fall 2025 Creator Insights Report provides marketers with predictive data on creator life events, purchasing decisions, and partnership preferences for strategic campaign planning

Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berlin 2025

NEWARK, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that data from the Phase 2b ANTHEM-UC study with icotrokinra in ulcerative colitis will be the focus of a brief oral presentation at the United European Gastroenterology Week 2025 being held in Berlin, Germany from October 4th through June 7th, 2025.

BOOKR Kids Launches BOOKR Next: A Revolutionary English Learning Platform for Teenagers

BOOKR Next encourages teenagers to transition from scrolling to storytelling

SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea

CHINO HILLS, CALIFORNIA / ACCESS Newswire / September 15, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing and Cell Engineering is pleased to announce that it has received a Notice of Allowance/Approval from the South Korea Patent Office for its innovative technology entitled - "CAS9 Retroviral Integrase and CAS9 Recombinase Systems for Targeted Incorporation of a DNA Sequence into a Genome of a Cell or Organism"

Percept Corporation Announces Patented MiOptics Therapeutic Optics Now Available Through the Top Independent Optical Labs in North America

Authorized Qualified Optical Labs include Cherry Optical, Complete Optical, OnSight Optical, Laramy-K Optical Lab, Pacific Artisan Labs and Plastic Plus.

Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study

-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump

Arizona Tribune - Boulevard (English)